Impact of the Prevention Clinic on Patient Outcomes

Project number: 
19-114
Approval date: 
Thursday, March 12, 2020
Principal Investigator: 
Darras,Pol
Institution: 
University of British Columbia (UBC)
Funding Agency: 
Not Available
Datasets requested: 
PharmaNet
Consolidation - demographic (Ministry of Health)
Deaths (BC Vital Statistics Agency)
consolidation - census geocodes
Hospital Separations (BC Ministry of Health)
Consolidation file (BC Ministry of Health)
Research objective: 

The primary objective of this study is to determine if attendance at the HHPPC is associated with reduced rates of adverse cardiovascular events. We will examine rates of myocardial infarction, stroke, transient ischemic attack, urgent revascularization, and all-cause mortality among patients with inherited dyslipidemia, which represents a high-risk group. We hypothesize that rates of ASCVD will be lower among patients who have attended the HHPPC, relative to those with inherited dyslipidemia who have not attended any of these clinics.

As a secondary objective, we will also assess other factors that may be associated with differences in rates of adverse cardiovascular events. This will include age, gender, and socioeconomic status (using the first three digits of the postal code as a proxy). We will also assess medication use patterns, including duration of therapy, among patients who did and did not attend one of the clinics.


Page last revised: May 5, 2020